Cargando…

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma

Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood c...

Descripción completa

Detalles Bibliográficos
Autores principales: Drees, Esther E. E., Driessen, Julia, Zwezerijnen, Gerben J. C., Verkuijlen, Sandra A. W. M., Eertink, Jakoba J., van Eijndhoven, Monique A. J., Groenewegen, Nils J., Vallés‐Martí, Andrea, de Jong, Daphne, Boellaard, Ronald, de Vet, Henrica C. W., Pegtel, Dirk M., Zijlstra, Josée M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422001/
https://www.ncbi.nlm.nih.gov/pubmed/36051072
http://dx.doi.org/10.1002/jha2.432
_version_ 1784777721376669696
author Drees, Esther E. E.
Driessen, Julia
Zwezerijnen, Gerben J. C.
Verkuijlen, Sandra A. W. M.
Eertink, Jakoba J.
van Eijndhoven, Monique A. J.
Groenewegen, Nils J.
Vallés‐Martí, Andrea
de Jong, Daphne
Boellaard, Ronald
de Vet, Henrica C. W.
Pegtel, Dirk M.
Zijlstra, Josée M.
author_facet Drees, Esther E. E.
Driessen, Julia
Zwezerijnen, Gerben J. C.
Verkuijlen, Sandra A. W. M.
Eertink, Jakoba J.
van Eijndhoven, Monique A. J.
Groenewegen, Nils J.
Vallés‐Martí, Andrea
de Jong, Daphne
Boellaard, Ronald
de Vet, Henrica C. W.
Pegtel, Dirk M.
Zijlstra, Josée M.
author_sort Drees, Esther E. E.
collection PubMed
description Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood count (CBC) with PET features (e.g., metabolic tumor volume [MTV], dissemination and intensity features) in 30 cHL patients at baseline. EV‐miR127‐3p, EV‐miR24‐3p, sTARC, and several CBC parameters showed weak to strong correlations with MTV and dissemination features, but not with intensity features. Two other EV‐miRNAs only showed weak correlations with PET features. Therefore, blood‐based biomarkers may be complementary to PET features, which warrants further exploration of combining these biomarkers in prognostic models.
format Online
Article
Text
id pubmed-9422001
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94220012022-08-31 Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma Drees, Esther E. E. Driessen, Julia Zwezerijnen, Gerben J. C. Verkuijlen, Sandra A. W. M. Eertink, Jakoba J. van Eijndhoven, Monique A. J. Groenewegen, Nils J. Vallés‐Martí, Andrea de Jong, Daphne Boellaard, Ronald de Vet, Henrica C. W. Pegtel, Dirk M. Zijlstra, Josée M. EJHaem Short Reports Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative (18)F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood count (CBC) with PET features (e.g., metabolic tumor volume [MTV], dissemination and intensity features) in 30 cHL patients at baseline. EV‐miR127‐3p, EV‐miR24‐3p, sTARC, and several CBC parameters showed weak to strong correlations with MTV and dissemination features, but not with intensity features. Two other EV‐miRNAs only showed weak correlations with PET features. Therefore, blood‐based biomarkers may be complementary to PET features, which warrants further exploration of combining these biomarkers in prognostic models. John Wiley and Sons Inc. 2022-04-28 /pmc/articles/PMC9422001/ /pubmed/36051072 http://dx.doi.org/10.1002/jha2.432 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Reports
Drees, Esther E. E.
Driessen, Julia
Zwezerijnen, Gerben J. C.
Verkuijlen, Sandra A. W. M.
Eertink, Jakoba J.
van Eijndhoven, Monique A. J.
Groenewegen, Nils J.
Vallés‐Martí, Andrea
de Jong, Daphne
Boellaard, Ronald
de Vet, Henrica C. W.
Pegtel, Dirk M.
Zijlstra, Josée M.
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title_full Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title_fullStr Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title_full_unstemmed Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title_short Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
title_sort blood‐circulating ev‐mirnas, serum tarc, and quantitative fdg‐pet features in classical hodgkin lymphoma
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422001/
https://www.ncbi.nlm.nih.gov/pubmed/36051072
http://dx.doi.org/10.1002/jha2.432
work_keys_str_mv AT dreesestheree bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT driessenjulia bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT zwezerijnengerbenjc bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT verkuijlensandraawm bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT eertinkjakobaj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT vaneijndhovenmoniqueaj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT groenewegennilsj bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT vallesmartiandrea bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT dejongdaphne bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT boellaardronald bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT devethenricacw bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT pegteldirkm bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma
AT zijlstrajoseem bloodcirculatingevmirnasserumtarcandquantitativefdgpetfeaturesinclassicalhodgkinlymphoma